Pea Protein-Derived Peptides Inhibit Hepatic Glucose Production via the Gluconeogenic Signaling in the AML-12 Cells

Pea protein is considered to be a high quality dietary protein source, but also it is an ideal raw material for the production of bioactive peptides. Although the hypoglycemic effect of pea protein hydrolysate (PPH) has been previously reported, the underlying mechanisms, in particular its effect on the hepatic gluconeogenesis, remain to be elucidated. In the present study, we found that PPH suppressed glucose production in mouse liver cell-line AML-12 cells. Although both of the gluconeogenic and insulin signaling pathways in the AML-12 cells could be regulated by PPH, the suppression of glucose production was dependent on the inhibition of the cAMP response element-binding protein (CREB)-mediated signaling in the gluconeogenic pathway, but not the activation of insulin signaling. Findings from the present study have unveiled a novel role of PPH underlying its anti-diabetic activity, which could be helpful to accelerate the development of functional foods and nutraceuticals using PPH as a starting material

Biology · CREB · Enzyme · Gluconeogenesis · Hydrolysate · Insulin · Phosphorylation · Signal transduction · Transcription factor · Biochemical effects in animals · Chemistry · GDF15 and Related Biomarkers · Medicine · Protein Hydrolysis and Bioactive Peptides · Biochemistry · Cell Biology · Endocrinology · Internal Medicine

• Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045

  Open Access•Pouya Saeedi, Inga Petersohn et al.•Diabetes Research and Clinical…•2019

  Add to list